CT
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$12.58
-3.05%
Mkt Cap $463.34M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $7.50M | — | — | -$0.50 | -$0.49 | +2.00% | — | — |
| Q4 2025 Oct 30, 2025 | $5.00M | — | — | -$0.58 | -$0.45 | +22.41% | — | — |
| Q3 2025 Aug 5, 2025 | $7.50M | — | — | -$0.56 | -$0.62 | -10.71% | — | — |
| Q2 2025 May 14, 2025 | $6.00M | — | — | -$0.56 | -$0.62 | -10.71% | — | — |
| Q1 2025 Mar 6, 2025 | — | — | — | -$0.44 | -$0.56 | -27.27% | — | — |
| Q4 2024 Nov 6, 2024 | — | — | — | -$0.41 | -$0.40 | +2.44% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.35 | -$0.39 | -11.43% | — | — |
| Q2 2024 May 16, 2024 | — | — | — | -$0.46 | -$3.55 | -671.74% | — | — |
| Q4 2023 Dec 31, 2023 | — | — | — | — | -$0.31 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | — | -$0.25 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | $50.00M | — | — | $1.62 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.19 | — | — | — |
| Q4 2022 Dec 31, 2022 | — | — | — | — | -$0.30 | — | — | — |